Lecture outline Types of hypersensitivity reactions Immediate hypersensitivity, allergy...
-
Upload
mathew-caron -
Category
Documents
-
view
217 -
download
7
Transcript of Lecture outline Types of hypersensitivity reactions Immediate hypersensitivity, allergy...
Lecture outline
• Types of hypersensitivity reactions
• Immediate hypersensitivity, allergy
• Antibody-mediated diseases
• T cell-mediated diseases
• Therapeutic approaches
Immunological (hypersensitivity) diseases
• Diseases caused by aberrant (excessive or uncontrolled) immune reactions– Reactions against self antigens (autoimmunity)– Uncontrolled or excessive reactions against foreign
antigens
• Underlying problem may be failure of self-tolerance and control mechanisms
• The nature of the disease is determined by the type of immune response– Diseases are classified based on immune
mechanisms: useful for understanding pathogenesis, but many diseases involve multiple mechanisms
Types of hypersensitivity disease
Type of hyper-sensitivity
Pathogenic immuneresponse
Mechanism oftissue injury
Immediate hyper-sensitivity (Type I)
IgE antibody, mast cells
Mast cell mediators
Antibody mediated(Type II)
IgM and IgG antibodiesagainst cell and matrixantigens
• Phagocytosis• Complement• Interference withcell functions
Immune complexmediated (Type III)
Complexes of circulatingantigens and IgM orIgG antibodies
Complement and Fcreceptor mediatedinflammation
T cell mediated(Type IV)
CD4 and CD8 T cells
• Cytokine-mediated inflammation
• Killing by CTLs
Immediate hypersensitivity reaction
Stages of immediate hypersensitivity reactions
Sequence of events in immediate hypersensitivity
Actions of mast cell mediators
Mast cell products are responsible for the manifestations of immediate hypersensitivity
Clinical manifestations of immediate hypersensitivity
Treatment of immediate hypersensitivity disorders
Genetic susceptibility for immediate hypersensitivity
• Allergic diseases run in families– Different members of the same family
may show different manifestations of immediate hypersensitivity (“atopy”)
• Multiple susceptibility genes have been identified by gene mapping and family studies– Genes may influence TH2 responses, IgE
production, mast cell activation, end-organ sensitivity
– Susceptibility loci identified include: HLA (immune responsiveness); cytokine gene cluster; others
How antibodies deposit in tissues
Antibody is specific for tissue antigen (typically self): disease is specific for target tissue
Antibody reacts with circulating antigen (self or foreign), and complexes tend to deposit in small vessels; not specific forany tissue
How antibodies cause disease -- 1
Neutrophils (and monocytes) are recruited by complement products (generated by the classical pathway) and binding to Fc tails of deposited antibodies, and are activated.Leukocyte recruitment and activation are part of inflammation.
Experimental models of immune complex diseases
• Serum sickness– Systemic immunization with large dose
of protein antigen --> circulating immune complexes --> complexes deposit in vessels and cause inflammation (Fc receptor and complement-mediated)
– Arthritis, vasculitis, glomerulonephritis
• Arthus reaction– Subcutaneous administration of antigen
in previously immunized individual --> formation and deposition of local immune complexes
– Cutaneous vasculitis
Immune complex-mediated glomerulonephritis
Anti-basement membrane antibody-mediated glomerulonephritis
How antibodies cause disease -- 2
Antibody and/or complement (C3b) are deposited on cell and are recognized by receptors for Fc or C3b on phagocytes --> coated (opsonized) cell is ingested and destroyed.Basis of autoantibody-mediated depletion of RBCs, platelets
How antibodies cause disease -- 3
Causes of antibody-mediated diseases
• Autoimmunity (production of autoantibodies)– May be due to failure of self-tolerance in
autoreactive B cells or helper T cells
• Antibody responses to foreign antigens– Antibodies against hepatitis B form
immune complexes --> vasculitis (polyarteritis nodosa)
– Post-streptococcal glomerulonephritis: immune complexes of Strep antigen + anti-Strep antibodies; formed in circulation or GBM
– Not known why immune complex diseases develop in rare individuals after common infections
How T cells injure tissues -- 1
CD4+ T cells respond to self (or microbial) antigens, produce cytokines that recruit and activate macrophages and neutrophils, and the products of these leukocytes damage tissues.
Recall that the same reaction destroys phagocytosed microbes (cell-mediated immunity, one arm of host defense)
Delayed type hypersensitivity (DTH) reaction
Detectable reaction to an antigen in a sensitized (previously exposed) individual
Caused mainly by CD4+ T cells cytokine secretion inflammation, macrophage activation
Morphology of a delayed type hypersensitivity (DTH) reaction
Classically attributed to Th1 response; may include Th17.
How T cells injure tissues -- 2
Cytotoxic T lymphocytes (CTLs) react against antigens in host tissues and kill (“lyse”) the host cells.
Causes of T cell-mediated hypersensitivity diseases
• Autoimmunity– Type 1 diabetes, multiple sclerosis,
rheumatoid arthritis, psoriasis
• Reaction to microbes and other foreign antigens– Contact sensitivity (DTH) to chemicals
(poison ivy)– Tuberculosis (granulomatous inflammation
in response to a persistent microbe: chronic DTH)
– Crohn’s disease (excessive Th1 and Th17 responses to gut commensals?)
– Viral hepatitis (CTLs kill virus-infected hepatocytes); not considered an example of “hypersensitivity”
Immune-mediated inflammatory diseases• Chronic diseases in which
inflammation is a prominent component and the immune system reacts excessively against one or more tissues - Major role of CD4+ T cells and cytokines;
antibodies may contribute to disease- Same therapies work in many of these
diseases• These diseases develop because the
normal controls on immune responses fail; typically due to autoimmunity but may be excessive reactions to microbes – MS, type 1 diabetes, RA: autoimmunity– Crohn’s: reaction against gut microbes?
Chronicity of immune-mediated inflammatory diseases
• Many of these hypersensitivity diseases are chronic and even self-perpetuating because:– The initiating stimuli cannot be
removed (self or environmental antigens, persistent microbes)
– The immune response tends to amplify itself (normally, enables few antigen-specific lymphocytes to deal with infections)
Amplification loop in DTH reactions
Cytokines are powerful amplifiers of immune reactions
Therapy of immune diseases: the current way
• Block the production or counteract the actions of effector molecules that cause tissue injury– Anti-inflammatory drugs, e.g.
steroids– Block T cell activation
(immunosuppressive drugs, e.g. cyclosporine)
– Deplete pathogenic antibodies (plasmapheresis), B or T lymphocytes (depleting antibodies)
• Empirical– Desensitization for allergy– Intravenous IgG (IVIg): engages
inhibitory FcR on B cells?
Therapy of immune disorders: rational approaches target lymphocyte activation and
subsequent inflammation
TCR
CD28
IL-12, IL-23 (p40)
T cell
IL-2
Inhibitors of calcineurin, various kinases
(inhibit signaling)
Anti-IL-2R(block cytokine
receptor)
CTLA-4.Ig (block costimulation)
TNF, IL-1, IL-6
IL-17A
APC
Anti-p40
TNF, IL-1, IL-6R
antagonists (block cytokines)
Anti-IL-17A
Inflammation Anti-integrin antibodies
(block adhesion)
Molecularly targeted therapies for immunological diseases: the rational
approach• Target the molecular basis of
lymphocyte activation and effector functions: rationally designed therapies– Based on understanding of lymphocyte
biology– Risks -- reactivation of infections
• Induce antigen-specific immunological tolerance: requires identification of target antigens– Being tried in MS, type 1 diabetes (in
which the major autoantigens are known)